Exercise Regimen for Breast

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Breast+1 More
Exercise Regimen - Other
Eligibility
18+
Female
What conditions do you have?
Select

Study Summary

This trial will compare the outcomes of two groups, one of which will receive a physical activity intervention while the other will only receive limited information on activity.

Eligible Conditions
  • Breast

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 4 Secondary · Reporting Duration:

Change in body composition
Change in laboratory values
Changes in CRP
Overall Survival
Quality of Life

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Control Group
1 of 2
Intervention Group
1 of 2

Active Control

Experimental Treatment

100 Total Participants · 2 Treatment Groups

Primary Treatment: Exercise Regimen · No Placebo Group · N/A

Intervention Group
Other
Experimental Group · 1 Intervention: Exercise Regimen · Intervention Types: Other
Control GroupNoIntervention Group · 1 Intervention: Control Group · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 5 years

Who is running the clinical trial?

VonsUNKNOWN
Nevada Cancer InstituteLead Sponsor
5 Previous Clinical Trials
64 Total Patients Enrolled
Karen Milligan, MDPrincipal InvestigatorNevada Cancer Institute

Eligibility Criteria

Age 18+ · Female Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are willing and able to participate in a prescribed exercise program.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 15th, 2021

Last Reviewed: November 15th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.